borderline significantP = 0.15
A borderline significant difference in lymph node size was observed in patients with malign and benign pathologies (2.2 ± 0.6 cm vs. 1.9 ± 0.4 cm; P = 0.15).
A borderline significant difference in lymph node size was observed in patients with malign and benign pathologies (2.2 ± 0.6 cm vs. 1.9 ± 0.4 cm; P = 0.15).
3 A, OS ( P = 0.001) rates were significantly higher in patients with benign histopathology compared to those with malign pathology, while there was a borderline significance ( P = 0.16) for patients with mediastinal lymph node SUV max ≤ 6.4 and those with SUV max > 6.4 ( Fig. 3 B).